De-Risk Regulatory Submissions Through Smarter LNP Characterization

Leverage Robust LNP Analytical Methods to Generate Reproducible Data, Ensure Product Consistency & Accelerate Confident Regulatory Submissions to Support Genetic Medicine Approvals

Having announced brand-new acquisitions between AbbVie and Capstan Therapeutics as well as Eli Lilly & Co and Verve Therapeutics, celebrating the huge attraction of leveraging LNPs for cell and gene therapies. There was never a better time for you and your team to join the only industry-led forum turbocharging LNP characterization to advance these drug products towards approval.

The 3rd LNP Characterization & Analytical Development Summit provided unrivalled, in-depth technical insights into how to overcome critical challenges in assessing targeted LNP surface functionalizationevaluating encapsulation efficiency for multivalent formulations, and aligning analytical results with process performance to build more robust regulatory submissions.

Colleagues joined experts from PfizerNovo NordiskPrime MedicineTessera TherapeuticsGSKSanofiVerve Therapeutics and more as they explored the cutting edge of LNP characterization and analytics. Don’t miss this opportunity to collaborate with the brightest minds shaping the future of LNP drug development in 2026.

I have attended every year’s LNP Characterization & Analytical Development Summit since its inauguration and learned from my industry and academic peers every year. It is a great opportunity for people working in this field to meet and share insights with each other, and I look forward to attending the summit again this year.

Zack Zhang, Director, Analytical Research & Development,
Beam Therapeutics

Beam Therapeutics Logo

What We Saw in 2025:

90+

Attendees from ​Large Pharma, Innovative Biotech & Academia

24+

Expert Speakers at the Forefront of LNP Analytical Development

16+

Data-Driven Sessions

8+

Hours of Dedicated Networking Sessions

6+

Deep Dive Workshops & Interactive Discussion Sessions

Opportunities for Networking & Knowledge Sharing

Image of a conference
Explore the Agenda

Experience a jam-packed agenda featuring the latest analytical advancements for targeted and multivalent LNPs, along with exclusive insights into cutting-edge characterization strategies for evaluating LNP size, morphology, and biodistribution

Image of a conference with partners showcasing their companies
Partner With Us

Position yourself alongside other leading analytical and assay solution providers to ensure your brand is at the heart of LNP deals and collaborations

Image of people at a conference
Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all a wide variety of analytical strategies for advancing LNP drug products, and make critical connections during our dedicated networking sessions